Literature DB >> 27192690

A Mechanism for Cancer-Associated Membranous Nephropathy.

Elion Hoxha1, Thorsten Wiech1, Phillip R Stahl1, Gunther Zahner1, Nicola M Tomas1, Catherine Meyer-Schwesinger1, Ulrich Wenzel1, Matthias Janneck1, Oliver M Steinmetz1, Ulf Panzer1, Sigrid Harendza1, Rolf A K Stahl1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27192690     DOI： 10.1056/NEJMc1511702

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  61 in total

1.  An Indirect Immunofluorescence Method Facilitates Detection of Thrombospondin Type 1 Domain-Containing 7A-Specific Antibodies in Membranous Nephropathy.

Authors:  Elion Hoxha; Laurence H Beck; Thorsten Wiech; Nicola M Tomas; Christian Probst; Swantje Mindorf; Catherine Meyer-Schwesinger; Gunther Zahner; Phillip R Stahl; Ruth Schöpper; Ulf Panzer; Sigrid Harendza; Udo Helmchen; David J Salant; Rolf A K Stahl
Journal:  J Am Soc Nephrol       Date:  2016-07-19       Impact factor: 10.121

2.  Circulating antibodies against M-type phospholipase A2 receptor and thrombospondin type-1 domain-containing 7A in Chinese patients with membranous nephropathy.

Authors:  Caixia Tian; Lian Li; Tanxin Liu; Xin Qu; Yurong Qiu
Journal:  Int Urol Nephrol       Date:  2019-06-21       Impact factor: 2.370

3.  Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases.

Authors:  A Radice; F Pieruzzi; B Trezzi; G Ghiggeri; P Napodano; M D'Amico; T Stellato; R Brugnano; F Ravera; D Rolla; G Pesce; M E Giovenzana; F Londrino; V Cantaluppi; F Pregnolato; A Volpi; G Rombolà; G Moroni; G Ortisi; Renato A Sinico
Journal:  J Nephrol       Date:  2017-10-28       Impact factor: 3.902

4.  Routine immunohistochemical staining in membranous nephropathy: in situ detection of phospholipase A2 receptor and thrombospondin type 1 containing 7A domain.

Authors:  Vincenzo L'Imperio; Federico Pieruzzi; Renato Alberto Sinico; Manuela Nebuloni; Antonio Granata; Andrew Smith; Antonella Radice; Fabio Pagni
Journal:  J Nephrol       Date:  2018-04-06       Impact factor: 3.902

5.  THSD7A as a marker for paraneoplastic membranous nephropathy.

Authors:  Tao Wang; Yan Zhang; MaoDong Liu; Xi Kang; Lin Kang; Hui Zhang
Journal:  Int Urol Nephrol       Date:  2019-01-03       Impact factor: 2.370

6.  Glomerular disease: Membranous nephropathy and the Henle-Koch postulates.

Authors:  Hans-Joachim Anders; Claudio Ponticelli
Journal:  Nat Rev Nephrol       Date:  2016-06-20       Impact factor: 28.314

Review 7.  [Membranous glomerulonephritis : An example of individualized medicine in nephrology].

Authors:  Rolf A K Stahl; Elion Hoxha
Journal:  Internist (Berl)       Date:  2019-05       Impact factor: 0.743

8.  Screening for Cancer in Patients with Glomerular Diseases.

Authors:  Emmanuelle Plaisier; Pierre Ronco
Journal:  Clin J Am Soc Nephrol       Date:  2020-02-04       Impact factor: 8.237

9.  The Most N-Terminal Region of THSD7A Is the Predominant Target for Autoimmunity in THSD7A-Associated Membranous Nephropathy.

Authors:  Larissa Seifert; Elion Hoxha; Anna M Eichhoff; Gunther Zahner; Silke Dehde; Linda Reinhard; Friedrich Koch-Nolte; Rolf A K Stahl; Nicola M Tomas
Journal:  J Am Soc Nephrol       Date:  2018-03-19       Impact factor: 10.121

Review 10.  Unmet challenges in membranous nephropathy.

Authors:  David J Salant
Journal:  Curr Opin Nephrol Hypertens       Date:  2019-01       Impact factor: 2.894
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.